NEU neuren pharmaceuticals limited

Angelman trial, page-65

  1. 2,524 Posts.
    lightbulb Created with Sketch. 690
    I am not sure either. The headline sounds pretty good. The stock is up 5% which doesn't sound like much, but they have a 7.3b~ market cap so it's a reasonable jump. Neuren knew we had competition in this indication but it will be interesting to compare results but it appears the endpoints may be different so that may be difficult ...

    Ionis announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndrome
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.